This supplement features updated information on late-breaking drug approvals for bleeding disorders, leukemia, and myeloma.
This special edition takes a deep dive into coverage from the 2015 ASH Annual Meeting, including interviews with speakers and up-to-date clinical findings presented at the meeting.
This special issue of ASH Clinical News features updates in the world of multiple myeloma, including treatment options, advancements in understanding the disease, and looking ahead to the landscape of care.
A special edition featuring drug updates from the 2014 ASH Annual Meeting.
12Page 2 of 2